CELL-FREE FETAL NUCLEIC ACIDS (cffNA) – NEW NON-INVASIVE PRENATAL DIAGNOSIS

Authors

  • M. ONOFRIESCU University of Medicine and Pharmacy”Grigore T. Popa” Iaşi

Abstract

Although these data support the use of cfDNA testing in women regardless of age or risk status, further cost utility studies are warranted. As emphasized by professional societies, the use of cfDNA testing and other genetic tests requires an explanation of the limitations and benefits of prenatal test choices to the patient.

Author Biography

  • M. ONOFRIESCU, University of Medicine and Pharmacy”Grigore T. Popa” Iaşi

    Faculty of Medicine
    Department of Mother and Child Medicine

Additional Files

Published

2015-06-30